Form 4: Perrigo Executive Alison Ives Reports Share Acquisition
SEC Form 4 Filing
Alison Ives, EVP & Chief Scientific Officer of Perrigo Co plc, reports the acquisition of 1,545 ordinary shares at $26.44 per share on February 29, 2024.
Summary
- Alison Ives, EVP & Chief Scientific Officer of Perrigo Co plc, filed a Form 4 on March 7, 2024, reporting a transaction.
- On February 29, 2024, Ms. Ives acquired 1,545 ordinary shares of Perrigo at a price of $26.44 per share.
- Following the reported transaction, Ms. Ives beneficially owns 12,446 ordinary shares.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It reflects an executive's share acquisition, which could be interpreted as a positive sign, but without further context, it's difficult to gauge the overall impact.
Positives
- The acquisition of shares by an executive could be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of regulatory compliance for publicly traded companies, providing transparency into the transactions of company insiders.
Stakeholder Impact
- Shareholders may view the executive's share purchase as a positive signal.
Key Dates
| Date | Description |
|---|---|
| 05/25/2022 | Date of Power of Attorney execution. |
| 02/29/2024 | Date of transaction: acquisition of ordinary shares. |
| 03/07/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.